Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Goddards Muscle lotion
1003020V0BBAAAA
|
Goddards | Turpentine oil | Musculoskeletal and Joint Diseases | No data available |
|
Golimumab 100mg/1ml inj pre-filled disposable devices
1001030X0AAACAC
|
Golimumab | Golimumab | Musculoskeletal and Joint Diseases | No data available |
|
Golimumab 50mg/0.5ml inj pre-filled syringes
1001030X0AAAAAA
|
Golimumab | Golimumab | Musculoskeletal and Joint Diseases | No data available |
|
Gosachew 1500mg chewable tablets
1001050A0BTAAAC
|
Gosachew | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Gosachew 500mg/400mg chewable tablets
1001050A0BTABAD
|
Gosachew | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Gosaveg 750mg tablets
1001050A0BYAAAB
|
Gosaveg | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Hedex Ibuprofen 200mg caplets
1001010J0CPAAAD
|
Hedex ibuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Hedex Ibuprofen 200mg tablets
1001010J0CPABAD
|
Hedex ibuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Higher Nature Vegetarian Glucosamine hydrochloride 800mg tab
1001050A0BIAAAG
|
Higher Nature (Glucosamine hydrochloride) | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Hulio 40mg/0.8ml solution for injection pre-filled pens
1001030S0BDAAAB
|
Hulio | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Hulio 40mg/0.8ml solution for injection pre-filled syringes
1001030S0BDABAA
|
Hulio | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Humira 40mg/0.4ml solution for injection pre-filled syringes
1001030S0BBAEAE
|
Humira | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Humira 40mg/0.8ml solution for injection pre-filled pens
1001030S0BBABAB
|
Humira | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Humira 40mg/0.8ml solution for injection pre-filled syringes
1001030S0BBAAAA
|
Humira | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Humira 40mg/0.8ml solution for injection vials
1001030S0BBACAC
|
Humira | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Humira 80mg/0.8ml solution for injection pre-filled pens
1001030S0BBAHAH
|
Humira | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Humira 80mg/0.8ml solution for injection pre-filled syringes
1001030S0BBAGAG
|
Humira | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Hyalase 1500unit powder for solution for injection ampoules
1003010P0BBAAAA
|
Hyalase | Hyaluronidase | Musculoskeletal and Joint Diseases | No data available |
|
Hyalgan 20mg/2ml solution for injection pre-filled syringes
1003010U0BBAAAA
|
Hyalgan | Hyaluronic acid sodium | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 108mg/5ml oral solution
1001030C0AABABA
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 120mg/5ml oral liquid
1001030C0AAAVAV
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 150mg/5ml oral liquid
1001030C0AAANAN
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 15mg/5ml oral solution
1001030C0AABCBC
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 160mg/5ml oral solution
1001030C0AAAPAP
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
|
Hydroxychloroquine 20mg/5ml oral solution
1001030C0AAAKAK
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.